Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Obesity Science & Innovation Europe (OSI EU)
6 November 2026
nhow Amsterdam RAIAmsterdam
Book Now
Menu
Book

Lucas Bethge
VP, Group Leader Chemistry at Silence Therapeutics
Speaker

Profile

Lucas Bethge studied chemistry at the Humboldt-University zu Berlin (Germany). After he obtained his Ph.D. in 2011 in Bioorganic Chemistry, he first joined NOXXON Pharma. In 2016 he moved to Silence Therapeutics GmbH, a biotech company in Berlin that develops GalNAc-conjugated siRNA for therapeutic use. Currently, he is Vice-President and leading the Oligonucleotide Chemistry group at Silence Therapeutics. Lucas is an expert for the synthesis, conjugation and analysis of oligonucleotides with over ten years of experience in industrial research and development at the interface between early research and clinical development.

Agenda Sessions

  • Presentation: Genetically-Validated INHBE Silencing with SLN098 siRNA for Enhanced Fat Loss and Lean Mass Preservation

    , 11:35
    View Session

At this event

Prev
Next
Ekaterina Grinko
Business Innovation & Partnerships Lead Obesity & GLP-1
Novo Nordisk

See Lucas at Obesity Science & Innovation Europe (OSI EU)

Book Now